Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Efficacy and tolerance of Tegeline® treatment in hypersensitivity syndrome. Immunological
study of the T cell index phenotype and functionality in hypersensitivity syndrome.